Oncure Drugs Private Limited
About Oncure Drugs Private Limited
Data last updated:
Oncure Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 25 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2020PTC350724. Its GSTIN is 27AADCO3250A1ZZ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhargavi Ashit Mehta and Ashit Sumanlal Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 301/302 Dynesty Business Park Andheri Kurla Road J.B.Nagar Andheri (Ea, Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.4 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net loss of ₹13.67 Lakh (net margin -213.6%) and EBITDA of ₹1.31 Lakh (EBITDA margin 20.4%).
Company details
Contact details
Oncure Drugs Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address301/302 Dynesty Business Park Andheri Kurla Road J.B.Nagar Andheri (Ea, Mumbai, Maharashtra, India – 400059
- IndustryPharma, API Manufacturers
To see the full contact details of Oncure Drugs Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Oncure Drugs is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Oncure Drugs Private Limited, buy the company report.
Financials of Oncure Drugs Private Limited
FY 2025 filings availableOncure Drugs Private Limited reported revenue of ₹6.4 Lakh (down 64% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 64% in the latest year. EBITDA fell 92% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1.31 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹13.67 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 20.4% | |||
| Net Profit Margin | -213.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Oncure Drugs Private Limited, buy the company report.
Board of directors of Oncure Drugs Private Limited
Oncure Drugs has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhargavi Ashit Mehta | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Ashit Sumanlal Mehta Also directs: Manan Cotsyn Private Limited, Sunrise Auxichem Private Limited, VKS Healthclub Equipments LLP and 5 more | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
| Harsh Ashit Mehta Also directs: Mazda Healthclub Equipments LLP, Sunrise Auxichem Private Limited, VKS Healthclub Equipments LLP and 1 more | Director | 25 Nov 2020 | 5 Years 11 Months | Current |
Auditor
Oncure Drugs Private Limited is audited by SOMAIYA & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SOMAIYA & CO. | FY 2023 | 121945W |
Shareholding
The shareholding of Oncure Drugs Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Oncure Drugs Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Oncure Drugs Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Oncure Drugs Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2021, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| B S M & Co. LLP |
To see the full MSME payment records of Oncure Drugs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Oncure Drugs Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
Oncure Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCO3250A1ZZ | Maharashtra | Active | 27 Sep 2023 |
To see the full GST registrations and return filing status of Oncure Drugs Private Limited, buy the company report.
Recent activity
Oncure Drugs Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Ashit Sumanlal Mehta was appointed as Director on 25 Nov 2020.
Frequently asked questions
Oncure Drugs is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 25 November 2020 (6+ years old) and is registered under CIN U24290MH2020PTC350724.
Oncure Drugs has 3 current directors:
- Bhargavi Ashit Mehta - Director
- Ashit Sumanlal Mehta - Director
- Harsh Ashit Mehta - Director
The latest financial statements of Oncure Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Oncure Drugs is 27AADCO3250A1ZZ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oncure Drugs is U24290MH2020PTC350724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oncure Drugs was incorporated on 25 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashit Sumanlal Mehta was appointed as Director on 25 Nov 2020. Bhargavi Ashit Mehta was appointed as Director on 25 Nov 2020. Harsh Ashit Mehta was appointed as Director on 25 Nov 2020.
Oncure Drugs has 2 MSME Form 1 returns on record for the period ending Mar 2021, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 28 Apr 2022.
The registered office of Oncure Drugs is at 301302 Dynesty Business Park Andheri Kurla Road J.B.Nagar Andheri Ea, Mumbai, Maharashtra, India – 400059.
Oncure Drugs operates in the pharma industry, in the api manufacturers segment.
Oncure Drugs can be reached at its registered office: 301302 Dynesty Business Park Andheri Kurla Road J.B.Nagar Andheri Ea, Mumbai, Maharashtra, India – 400059.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
